FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approves a supplemental labeling application for Vesicare (solifenacin succinate) from Astellas Pharma US, updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

SUPPL AP for VESICARE (SOLIFENACIN SUCCINATE)